143 related articles for article (PubMed ID: 34941149)
1. Retinopathy in Egyptian patients with sickle cell disease: A cross-sectional study.
Hassan T; Badr M; Hanna D; Arafa M; Elhewala A; Dabour S; Shehata S; Rahman DA
Medicine (Baltimore); 2021 Dec; 100(51):e28355. PubMed ID: 34941149
[TBL] [Abstract][Full Text] [Related]
2. Optical Coherence Tomography Angiography and Ultra-widefield Fluorescein Angiography for Early Detection of Adolescent Sickle Retinopathy.
Pahl DA; Green NS; Bhatia M; Lee MT; Chang JS; Licursi M; Briamonte C; Smilow E; Chen RWS
Am J Ophthalmol; 2017 Nov; 183():91-98. PubMed ID: 28860042
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Optical Coherence Tomography in the Early Identification of Children with Sickle Cell Retinopathy.
Abdelkader A; Shaaban M; Zahran MM; Mohammed MF; Ebrahim AM; Galhoom AI
Int J Clin Pract; 2022; 2022():9131423. PubMed ID: 36105789
[TBL] [Abstract][Full Text] [Related]
4. Early diagnosis of sickle cell retinopathy by using ocular coherence tomography in pediatric population (7-18 years) in central India.
Soni P; Dhingra B; Karkhur S; Chaudhary NK; Pakhare AP
Pediatr Blood Cancer; 2024 Jul; 71(7):e31021. PubMed ID: 38644611
[TBL] [Abstract][Full Text] [Related]
5. Sickle cell retinopathy. A focused review.
Abdalla Elsayed MEA; Mura M; Al Dhibi H; Schellini S; Malik R; Kozak I; Schatz P
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1353-1364. PubMed ID: 30895451
[TBL] [Abstract][Full Text] [Related]
6. Sickle Eye Project: a cross-sectional, non-interventional study of the prevalence of visual impairment due to sickle cell retinopathy and maculopathy in the UK.
Dinah C; Balaskas K; Greystoke B; Awadzi R; Beke P; Ahern R; Talks J
BMJ Open; 2024 Feb; 14(2):e082471. PubMed ID: 38418238
[TBL] [Abstract][Full Text] [Related]
7. Sickle cell retinopathy: What we now understand using optical coherence tomography angiography. A systematic review.
Leitão Guerra RL; Leitão Guerra CL; Bastos MG; de Oliveira AHP; Salles C
Blood Rev; 2019 May; 35():32-42. PubMed ID: 30852057
[TBL] [Abstract][Full Text] [Related]
8. Monitoring retinal pathology and cerebral injury in sickle cell disease using spectral-domain optical coherence tomography in pediatric patients.
Jin J; Kandula V; Miller RE
Pediatr Blood Cancer; 2021 Jul; 68(7):e29028. PubMed ID: 33788385
[TBL] [Abstract][Full Text] [Related]
9. [Role of OCT-angiography in the management of sickle cell retinopathy].
Croisé F; Le Lez ML; Pisella PJ
J Fr Ophtalmol; 2020 Jan; 43(1):7-17. PubMed ID: 31831271
[TBL] [Abstract][Full Text] [Related]
10. New Ways to Detect Pediatric Sickle Cell Retinopathy: A Comprehensive Review.
Pahl DA; Green NS; Bhatia M; Chen RWS
J Pediatr Hematol Oncol; 2017 Nov; 39(8):618-625. PubMed ID: 28737601
[TBL] [Abstract][Full Text] [Related]
11. TEMPORAL THINNING IN SICKLE CELL RETINOPATHY IS ASSOCIATED WITH DIMINISHED PERFUSION ON OCTA AND DENSE SCOTOMA ON MICROPERIMETERY.
Sambhav K; Grover S; Chalam KV
Retin Cases Brief Rep; 2019; 13(4):308-313. PubMed ID: 28644178
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal Assessment of Retinal Thinning in Adults With and Without Sickle Cell Retinopathy Using Spectral-Domain Optical Coherence Tomography.
Lim JI; Niec M; Sun J; Cao D
JAMA Ophthalmol; 2021 Mar; 139(3):330-337. PubMed ID: 33538815
[TBL] [Abstract][Full Text] [Related]
13. Optical coherence tomography (OCT) and OCT angiography allow early identification of sickle cell maculopathy in children and correlate it with systemic risk factors.
Grego L; Pignatto S; Alfier F; Arigliani M; Rizzetto F; Rassu N; Samassa F; Prosperi R; Barbieri F; Dall'Amico R; Cogo P; Lanzetta P
Graefes Arch Clin Exp Ophthalmol; 2020 Nov; 258(11):2551-2561. PubMed ID: 32518974
[TBL] [Abstract][Full Text] [Related]
14. ATYPICAL FOVEAL AND PARAFOVEAL ABNORMALITIES IN SICKLE CELL DISEASE.
Orssaud C; Flammarion E; Michon A; Ranque B; Arlet JB
Retina; 2024 Mar; 44(3):506-514. PubMed ID: 37948742
[TBL] [Abstract][Full Text] [Related]
15. Terminology for Retinal Findings in Sickle Cell Disease Research: A Scoping Review.
Reilly GR; Xie Y; Scherer RW; Hawkins BS; Lanzkron SM; Scott AW
Ophthalmol Retina; 2024 Jan; 8(1):81-87. PubMed ID: 37634744
[TBL] [Abstract][Full Text] [Related]
16. Sickle Cell Maculopathy: Microstructural Analysis Using OCTA and Identification of Genetic, Systemic, and Biological Risk Factors.
Fares S; Hajjar S; Romana M; Connes P; Acomat M; Zorobabel C; Zuber K; Boulanger-Scemama E; Etienne-Julan M; David T; Beral L
Am J Ophthalmol; 2021 Apr; 224():7-17. PubMed ID: 33412123
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Macular Vascular Abnormalities Identified by Optical Coherence Tomography Angiography in Sickle Cell Disease.
Han IC; Tadarati M; Pacheco KD; Scott AW
Am J Ophthalmol; 2017 May; 177():90-99. PubMed ID: 28212878
[TBL] [Abstract][Full Text] [Related]
18. Paracentral acute middle maculopathy: precursor to macular thinning in sickle cell retinopathy.
Hussnain SA; Coady PA; Stoessel KM
BMJ Case Rep; 2017 Apr; 2017():. PubMed ID: 28446442
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous Reversal of Peripheral Nonperfusion in Sickle Cell Retinopathy.
Ramtohul P; Minvielle W; Couturier A
Ophthalmol Retina; 2021 Jul; 5(7):695. PubMed ID: 34243971
[No Abstract] [Full Text] [Related]
20. Ophthalmic Manifestations of Sickle Cell Disease.
Scott AW
South Med J; 2016 Sep; 109(9):542-8. PubMed ID: 27598358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
